Shopping Cart
- Remove All
- Your shopping cart is currently empty
AM-2099 is a selective voltage-gated sodium channel Nav1.7 inhibitor used in pain research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $278 | 5 days | |
5 mg | $409 | In Stock |
Description | AM-2099 is a selective voltage-gated sodium channel Nav1.7 inhibitor used in pain research. |
Targets&IC50 | Nav1.7 (mouse):0.18 μM, Nav1.7 (rat):3.5 μM, Nav1.7 (human):0.16 μM |
In vitro | AM-2099 is more than 100-fold selective over Nav1.3, Nav1.4, Nav1.5, and Nav1.8, while lower levels of selectivity are observed against Nav1.1, Nav1.2, and Nav1.6. AM-2099 demonstrates low affinity for hERG (>30 µM) and does not show greater than 50% inhibition against a panel of 100 kinases (1 µM) and a broad CEREP panel (10 µM). In heterologous cells, comparable inhibition is observed across human, mouse, dog, and cynomolgus monkey NaV1.7 with reduced activity against rat NaV1.7.[1] |
In vivo | AM-2099 demonstrates a dose-dependent increase in plasma exposure with a concomitant dose-dependent reduction in scratching bouts compared to vehicle-treated animals, with a statistically significant reduction observed at the 60 mg/kg dose. AM-2099 demonstrates a favorable pharmacokinetic profile in rat and dog. In rats AM-2099 shows low total clearance and moderate Vdss and half-life. However, when dosed in dogs AM-2099 shows very low clearance, a low Vdss and long halflife (18 h).[1] |
Alias | AM2099 |
Molecular Weight | 466.46 |
Formula | C19H13F3N4O3S2 |
Cas No. | 1443373-17-8 |
Smiles | O=S(=O)(NC1=NC=CS1)C=2C=CC=3C(=NC=NC3C=4C=CC(=CC4OC)C(F)(F)F)C2 |
Relative Density. | 1.531 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 120 mg/mL (257.26 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.